Direktorat Registrasi ObatValid

ZIFIVAX

BPOM Number: EUA2160800143A1
Approved: 21 November 2024
Expiry: —
Form: INJEKSI; 0,025 MG

About This Registration

ZIFIVAX is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number EUA2160800143A1. Its current registration status is Valid. The product is registered to JAKARTA BIOPHARMACEUTICAL INDUSTRY - INDONESIA. BPOM first approved this registration in October 2021. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: Registrasi Obat
Packaging: Dus, 1 vial @ 1 dosis (0,5 mL)
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

JAKARTA BIOPHARMACEUTICAL INDUSTRY - INDONESIA
KAB. SERANG
NPWP: 940262470454000
owner
View profile →

Manufacturing Sites

JAKARTA BIOPHARMACEUTICAL INDUSTRY - INDONESIA
KAB. SERANG
primary
View profile →

Ingredients (1)

RECOMBINANT PROTEIN NCP-RBD OF SARS COV-2 VIRUS

Market Intelligence

Owner Portfolio: JAKARTA BIOPHARMACEUTICAL INDUSTRY - INDONESIA holds 5 BPOM registrations
Manufacturer Scale: JAKARTA BIOPHARMACEUTICAL INDUSTRY - INDONESIA produces 5 registered products
Registration Age: Registered for 4 years, 10 months